These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3151755)

  • 21. Lack of sensitivity of sister-chromatid exchange for lymphocyte chromosomal damage detection caused by antichagasic treatment.
    Gorla NB; Ledesma OS; Barbieri GP; Larripa IB
    Toxicol Lett; 1991 Oct; 58(2):225-30. PubMed ID: 1949081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicity of nifurtimox as second-line treatment after benznidazole intolerance in patients with chronic Chagas disease: when available options fail.
    Crespillo-Andújar C; Chamorro-Tojeiro S; Norman F; Monge-Maillo B; López-Vélez R; Pérez-Molina JA
    Clin Microbiol Infect; 2018 Dec; 24(12):1344.e1-1344.e4. PubMed ID: 29906591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrastructural effects of Nifurtimox on rat adrenal cortex related to reductive biotransformation.
    de Castro CR; De Toranzo EG; Carbone M; Castro JA
    Exp Mol Pathol; 1990 Feb; 52(1):98-108. PubMed ID: 2106446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic efficacy of allopurinol in patients with chronic Chagas' disease.
    Gallerano RH; Marr JJ; Sosa RR
    Am J Trop Med Hyg; 1990 Aug; 43(2):159-66. PubMed ID: 2117857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benznidazole and nifurtimox nitroreductase activity in liver microsomes from male rats preinduced with phenobarbital or 3-methylcholanthrene.
    Aguilar EG; de Arranz CK; de Toranzo EG; Castro JA
    Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):443-6. PubMed ID: 3841223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current status of Chagas disease chemotherapy.
    Guedes PM; Silva GK; Gutierrez FR; Silva JS
    Expert Rev Anti Infect Ther; 2011 May; 9(5):609-20. PubMed ID: 21609270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas' disease.
    Jackson Y; Wyssa B; Chappuis F
    J Antimicrob Chemother; 2020 Mar; 75(3):690-696. PubMed ID: 31754690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitroreduction of benznidazole and nifurtimox by rat and human feces.
    de Toranzo EG; Masana M; Castro JA
    Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):341-4. PubMed ID: 6688884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanocarriers for effective delivery of benznidazole and nifurtimox in the treatment of chagas disease: A review.
    Arrúa EC; Seremeta KP; Bedogni GR; Okulik NB; Salomon CJ
    Acta Trop; 2019 Oct; 198():105080. PubMed ID: 31299283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Etiologic therapy of Chagas' disease].
    Boainain E; Rassi A
    Arq Bras Cardiol; 1979 Jun; 32(6):395-9. PubMed ID: 116629
    [No Abstract]   [Full Text] [Related]  

  • 31. [Etiological treatment of Chagas' disease].
    Rassi A
    Arq Bras Cardiol; 1982 Apr; 38(4):277-81. PubMed ID: 6820273
    [No Abstract]   [Full Text] [Related]  

  • 32. [Undesirable effects of nifurtimox and benznidazole].
    Laplumé H; Barousse AP; Cabrera H
    Medicina (B Aires); 1982; 42(2):223. PubMed ID: 7144529
    [No Abstract]   [Full Text] [Related]  

  • 33. [Allopurinol in the treatment of chronic Chagas' disease].
    Meirovich CI; Montrull HL; Gallerano RH; Sosa RR
    Arq Bras Cardiol; 1985 Sep; 45(3):217-23. PubMed ID: 3939099
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolization of nifurtimox and benznidazole in cellular fractions of rat mammary tissue.
    Bartel LC; Montalto de Mecca M; de Castro CR; Bietto FM; Castro JA
    Hum Exp Toxicol; 2010 Oct; 29(10):813-22. PubMed ID: 20150355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitrypanosomal therapy for chronic Chagas' disease.
    Bern C
    N Engl J Med; 2011 Jun; 364(26):2527-34. PubMed ID: 21714649
    [No Abstract]   [Full Text] [Related]  

  • 36. Combination Therapy Using Benznidazole and Aspirin during the Acute Phase of Experimental Chagas Disease Prevents Cardiovascular Dysfunction and Decreases Typical Cardiac Lesions in the Chronic Phase.
    Pereira RS; Malvezi AD; Lovo-Martins MI; Lucchetti BFC; Santos JP; Tavares ER; Verri WA; de Almeida Araújo EJ; Yamauchi LM; Yamada-Ogatta SF; Martins-Pinge MC; Pinge-Filho P
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of complement mediated lysis technic in patients with chronic Chagas' disease treated with trypanocidal drugs].
    Levy AM; Pereira VL; Boainain E
    Rev Inst Med Trop Sao Paulo; 1988; 30(1):32-9. PubMed ID: 3146793
    [No Abstract]   [Full Text] [Related]  

  • 38. [Longitudinal study of the persistence of the therapeutic action of nifurtimox and benznidazole in patients with chronic chagas infection].
    Schenone H; Rojas A; Alfaro E; Concha L; Aranda R
    Bol Chil Parasitol; 1981; 36(3-4):59-62. PubMed ID: 6812600
    [No Abstract]   [Full Text] [Related]  

  • 39. First century of Chagas' disease: an overview on novel approaches to nifurtimox and benzonidazole delivery systems.
    Salomon CJ
    J Pharm Sci; 2012 Mar; 101(3):888-94. PubMed ID: 22161779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of Chagas' disease with nifurtimox during the first months of life].
    Moya PR; Paolasso RD; Blanco S; Lapasset M; Sanmartino C; Basso B; Moretti E; Cura D
    Medicina (B Aires); 1985; 45(5):553-8. PubMed ID: 3939553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.